Bogle Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bogle Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-106,935	Closed	-$1.94M	–	383
2018 Q1	$1.94M	Buy	+106,935	New	+$1.78M	0.15%	152
2017 Q4	–	Sell	-373,408	Closed	-$6.91M	–	390
2017 Q3	$6.91M	Sell	373,408 -59,652	-14%	-$997K	0.47%	84
2017 Q2	$7.32M	Buy	+433,060	New	+$6.59M	0.53%	80
2016 Q4	–	Sell	-110,047	Closed	-$1.29M	–	438
2016 Q3	$1.29M	Buy	110,047 +98,779	+877%	+$1.16M	0.09%	222
2016 Q2	$121K	Buy	+11,268	New	+$116K	0.01%	371
2015 Q4	–	Sell	-27,482	Closed	-$450K	–	467
2015 Q3	$450K	Sell	27,482 -599,234	-96%	-$12.3M	0.03%	316
2015 Q2	$14.3M	Buy	626,716 +528,224	+536%	+$10.5M	1.07%	6
2015 Q1	$1.5M	Buy	+98,492	New	+$1.28M	0.1%	224
2014 Q3	–	Sell	-21,614	Closed	-$261K	–	423
2014 Q2	$261K	Buy	+21,614	New	+$255K	0.02%	305

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bogle Investment Management's MNTA Position: Q2 2018 in Review

Bogle Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2018, closing a stake of 106,935 shares — an estimated $1.94M sold.

Bogle Investment Management first reported a position in MNTA in Q2 2014 and held it in 9 quarters. The position peaked at $14.3M in Q2 2015. 160 funds tracked by Wall St. Rank hold MNTA as of Q2 2018.

Bogle Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Bogle Investment Management sold 106,935 Momenta Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1.94M.
Bogle Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
Bogle Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $14.3M in Q2 2015.
160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2018.

Based on Bogle Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.